Bausch Health Cos Cost of Goods Sold 2010-2024 | BHC

Bausch Health Cos cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Bausch Health Cos Annual Cost of Goods Sold
(Millions of US $)
2023 $2,559
2022 $2,364
2021 $2,394
2020 $2,249
2019 $2,350
2018 $2,351
2017 $2,548
2016 $2,611
2015 $2,585
2014 $2,236
2013 $1,905
2012 $970
2011 $696
2010 $406
2009 $218
Bausch Health Cos Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $696
2024-06-30 $719
2024-03-31 $640
2023-12-31 $705
2023-09-30 $623
2023-06-30 $649
2023-03-31 $582
2022-12-31 $652
2022-09-30 $584
2022-06-30 $577
2022-03-31 $551
2021-12-31 $626
2021-09-30 $582
2021-06-30 $612
2021-03-31 $574
2020-12-31 $645
2020-09-30 $590
2020-06-30 $495
2020-03-31 $519
2019-12-31 $635
2019-09-30 $584
2019-06-30 $594
2019-03-31 $537
2018-12-31 $602
2018-09-30 $582
2018-06-30 $594
2018-03-31 $573
2017-12-31 $647
2017-09-30 $659
2017-06-30 $646
2017-03-31 $596
2016-12-31 $665
2016-09-30 $658
2016-06-30 $658
2016-03-31 $630
2015-12-31 $730
2015-09-30 $648
2015-06-30 $685
2015-03-31 $522
2014-12-31 $571
2014-09-30 $561
2014-06-30 $586
2014-03-31 $518
2013-12-31 $732
2013-09-30 $575
2013-06-30 $298
2013-03-31 $300
2012-12-31 $218
2012-09-30 $230
2012-06-30 $210
2012-03-31 $312
2011-12-31 $154
2011-09-30 $166
2011-06-30 $173
2011-03-31 $203
2010-12-31 $214
2010-09-30 $63
2010-06-30 $67
2010-03-31 $62
2009-12-31 $73
2009-09-30 $51
2009-06-30 $50
2009-03-31 $45
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.012B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00